Background:  Relax-Cardio is a multicenter, randomized, double-blind, crossover placebo-controlled Phase II study to assess the effect of serelaxin versus placebo on high-sensitivity cardiac troponin I (hs-cTnI) release in patients with chronic heart failure after exercise when used in addition to standard of care. Trial Registration No: NCT02625922 (clinicaltrials.gov) Link  Trial Status: Study stopped Randomized worldwide: 1 (of N=120)  Randomized in Basel: 1 (of N=10) Enrolling Centers:  Switzerland Worldwide: University Hospital Basel  4 in Germany  4 in UK  Core Study Team: 
© Christian Mueller, 2012 - 2017  │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: October 2017
Ursina Honegger Dr. Beate Hartmann Dr. Samyut Shrestha Dr. Zaid Sapti Dr. Janosch Cupa Kristin Podkowik Home News Team Studies Publications Events Cooperations Contact